Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zena is a prescription medication containing a benzodiazepine, used primarily to treat epilepsy (seizures) and anxiety disorders. It acts by decreasing abnormal and excessive activity of nerve cells in the brain, thereby calming the central nervous system. As with other benzodiazepines, it has muscle relaxant properties and may be used to stop seizures or relax tense muscles. The drug carries a high potential for habit formation and should only be taken as prescribed by a physician. Common side effects include fatigue, depression, impaired coordination, dizziness, and sleepiness; abrupt discontinuation can increase seizure frequency or cause withdrawal symptoms such as nausea, anxiety, flu-like symptoms, and muscle pain[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zena.